Two inverse vaccines from Nykode Therapeutics — developed to teach the immune system not to respond against its own body — worked to reduce disease severity in a mouse model of multiple sclerosis(MS), new data show.
This adds to earlier findings that the company’s experimental approach and its TV004 inverse vaccine can prevent the disease from developing in mice by making the immune system unresponsive to a protein involved in MS — without fully disrupting the immune response……read full story HERE.